First FDA-Approved Pancrelipase Product May Mark New Era for Providers, Patients
FDA’s recent approval of a reformulated version of Solvay Pharmaceutical Inc.’s delayed-release pancrelipase product, Creon, gives pharmacists who are active in the cystic fibrosis community something newa ‘a pancreatic enzyme product that has passed regulatory muster.
No Comments
RSS feed for comments on this post.
by Raelene
